Answers are grounded in this paper and cite their sources.
Clinical study finds serum albumin correlates with mortality in sepsis patients, suggesting its use as a prognostic marker.
Sepsis is a life-threatening condition characterized by organ dysfunction resulting from a dysregulated host response to infection. Despite advances in critical care, sepsis continues to account for high morbidity and mortality worldwide, with an estimated 48.9 million cases and 11 million deaths annually. Prognostic tools such as Sequential Organ Failure Assessment (SOFA) and Acute Physiology and Chronic Health Evaluation (APACHE II) are widely used but remain resource-intensive, particularly in low- and middle-income countries. Therefore, identifying simple, cost-effective biomarkers is crucial for improving clinical outcomes. Serum albumin, a vital plasma protein with roles in colloid osmotic pressure, transport, antiinflammatory, and antioxidant activities, has emerged as a potential predictor of sepsis severity and prognosis. Hypoalbuminemia is frequently observed in septic patients, resulting from capillary leakage, impaired synthesis, and increased catabolism. Several studies suggest that decreased serum albumin levels are associated with higher mortality, increased vasopressor requirements, renal replacement therapy, and prolonged intensive care unit (ICU) stay. Clinical trials such as the SAFE and ALBIOS studies demonstrated the safety of albumin administration but failed to establish clear survival benefits, though subgroup analyses indicate potential advantages in septic shock patients. Recent observational studies also support serum albumin as an independent prognostic factor, with lower levels correlating with worse outcomes. This paper aims to evaluate the prognostic significance of serum albumin in sepsis, particularly its role in predicting severity and mortality in ICU patients. While controversies remain regarding therapeutic supplementation, serum albumin measurement represents a practical tool for early risk stratification and outcome prediction in sepsis management.
No takes yet. Share an insight, caveat, or question.
Godara et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: